Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Community & Family Medicine Volume 1 (2016), Article ID 1:IJCFM-101, 6 pages
https://doi.org/10.15344/2456-3498/2016/101
Research Article
The Impact of Antidepressant Treatment Adherence on the Use of Diagnostic Radiology and Laboratory Tests in Patients with Depressive/Anxiety Disorders: A Population-Based Study

Trifirò G1*, Sultana J2, Parrino F3, Tari DU4, Fontana A5, Giorgianni F6, Ferrajolo C7, Troncone C8, Ientile V9 and Caputi AP10

1Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Policlinico Universitario G. Martino, University of Messina, Italy and Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands
2Department of Clinical and Experimental Medicine, Pharmacology Section, University of Messina, Italy
3Department of Clinical and Experimental Medicine, Pharmacology Section, University of Messina, Italy
4Caserta - Local Health Service, Caserta, Italy
5Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
6Department of Clinical and Experimental Medicine, Pharmacology Section, University of Messina, Italy
7Department of Experimental Medicine, Pharmacology section, Second University of Naples, Italy
8Caserta - Local Health Service, Caserta, Italy
9Department of Clinical and Experimental Medicine, Pharmacology Section, University of Messina, Italy
10Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Policlinico Universitario G. Martino, University of Messina, Italy
Dr. Gianluca Trifirò, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Policlinico Universitario G. Martino, University of Messina, Via Consolare Valeria, 98125, Messina, Italy, Tel: +39 0902213264; E-mail: trifirog@unime.it
01 November 2015; 07 January 2016; 09 January 2016
Trifirò G, Sultana J, Parrino F, Tari DU, Fontana A, et al. (2016) The Impact of Antidepressant Treatment Adherence on the Use of Diagnostic Radiology and Laboratory Tests in Patients with depressive/Anxiety Disorders: a Population-Based Study. Int J Community Fam Med 1: 101. doi: https://doi.org/10.15344/2456-3498/2016/101
© 2016 Trifiro et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. World Health Organization (2012) Depression Fact sheet N°369 [View]
  2. Baxter AJ, Scott KM, Vos T, WhitefordHA (2013) Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med 43: 897-910 [CrossRef] [Google Scholar] [PubMed]
  3. Miret M, Ayuso-Mateos JL, Sanchez-Moreno J, Vieta E (2013) Depressive disorders and suicide: Epidemiology, risk factors, and burden. Neurosci Biobehav Rev 37: 2372-2374 [CrossRef] [Google Scholar] [PubMed]
  4. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993) The economic burden of depression in 1990. J Clin Psychiatry 54: 405-418 [Google Scholar] [PubMed]
  5. Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F (2000) Depression: costof- illness studies in the international literature, a review. J Ment Health Policy Econ 3: 3-10 [CrossRef] [Google Scholar] [PubMed]
  6. Olchanski N, McInnis Myers M, Halseth M, Cyr PL, Bockstedt L, et al. (2013) The economic burden of treatment-resistant depression. Clin Ther 35: 512-522 [CrossRef] [Google Scholar] [PubMed]
  7. Simon GE, VonKorff M, Barlow W (1995) Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry 52: 850-856 [CrossRef] [Google Scholar] [PubMed]
  8. Fostick L, Silberman A, Beckman M, Spivak B, Amital D (2010) The economic impact of depression: resistance or severity? Eur Neuropsychopharmacol 20: 671-675 [CrossRef] [Google Scholar] [PubMed]
  9. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43: 521-530 [CrossRef] [Google Scholar] [PubMed]
  10. Roebuck MC, Liberman JN, Gemmill-Toyama M, BrennanTA (2011) Medication adherence leads to lower healthcare use and costs despite increased drug spending. Health Affairs 30: 91-99 [CrossRef] [Google Scholar] [PubMed]
  11. Krousel-Wood M, Thomas S, Muntner P, Morisky D (2004) Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19: 357-362 [CrossRef] [Google Scholar] [PubMed]
  12. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, et al. (2010) Patient, physician, and payment predictors of statin adherence. Med Care 48: 196- 202 [CrossRef] [Google Scholar] [PubMed]
  13. Shin DW, Park JH, Park JH, Park EC, Kim SY, et al. (2010) Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer 19: 211-220 [CrossRef] [Google Scholar] [PubMed]
  14. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB (2009) Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 15: 728-740 [CrossRef] [Google Scholar] [PubMed]
  15. Ostrowski M (2007) Report takes aim at America’s other drug problem: Poor adherence. J Fam Practice 56: 734 [Google Scholar]
  16. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC (2006) Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 44: 300-303 [CrossRef] [Google Scholar] [PubMed]
  17. Alacqua M, Trifirò G, Spina E, Moretti S, Tari DU, et al. (2009) Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. Epilepsy Res 85: 107-113 [CrossRef] [Google Scholar] [PubMed]
  18. Ingrasciotta Y, Sultana J, Giorgianni F, Caputi AP, Arcoraci V, et al. (2014) The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS One 9 : e89072 [CrossRef] [Google Scholar] [PubMed]
  19. Piacentini N, Trifiró G, Tari M, Moretti S, Arcoraci V; UVEC group (2005) Statin-macrolide interaction risk: a population-based study throughout a general practice database. Eur J Clin Pharmacol 61: 615-620 [CrossRef] [Google Scholar] [PubMed]
  20. Trifirò G, Corrao S, Alacqua M, Moretti S, Tari M, et al. (2006) Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources. Br J Clin Pharmacol 62: 582-590 [CrossRef] [Google Scholar] [PubMed]
  21. Trifirò G, Alacqua M, Corrao S, Moretti S, Tari DU, et al. (2008) Lipidlowering drug use in Italian primary care: effects of reimbursement criteria revision. Eur J Clin Pharmacol 64: 619-625 [CrossRef] [Google Scholar] [PubMed]
  22. Trifirò G, Savica R, Morgante L, Vanacore N, Tari M, et al. (2008) Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005. Parkinsonism & Related Disorders14: 420-425 [CrossRef] [Google Scholar] [PubMed]
  23. Alacqua M, Trifirò G, Cavagna L, Caporali R, Montecucco CM, et al. (2008) Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. Arthritis Rheum 59: 568-574 [CrossRef] [Google Scholar] [PubMed]
  24. Oteri A, Trifirò G, Gagliostro MS, Tari DU, Moretti S, et al. (2010) Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07. J Clin Pharmacol 70: 514-522 [CrossRef] [Google Scholar] [PubMed]
  25. Trifirò G, Barbui C, Spina E, Moretti S, Tari M, et al. (2007) Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 16: 552-559 [CrossRef] [Google Scholar] [PubMed]
  26. Robinson RL, Long SR, Chang S, Able S, Baser O, et al. (2006) Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharm 12: 43-54 [CrossRef] [Google Scholar] [PubMed]
  27. Sawada N, Uchida H, Suzuki T, Watanabe K, Kikuchi T, et al. (2009) Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry 9: 38 [CrossRef] [Google Scholar] [PubMed]
  28. Aguglia E, Ravasio R, Simonetti M, Pecchioli S, Mazzoleni F (2012) Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003-2009. Curr Med Res Opin 28: 1475-1484 [CrossRef] [Google Scholar] [PubMed]
  29. Parabiaghi A, Franchi C, Tettamanti M, Barbato A, D'Avanzo B, et al. (2011) Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. Eur J Clin Pharmacol 67: 1077- 1083 [CrossRef] [Google Scholar] [PubMed]
  30. Trifirò G, Tillati S, Spina E, Ferrajolo C, Alacqua M, et al. (2013) A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 69: 227-236 [CrossRef] [Google Scholar] [PubMed]
  31. Qin B, Zhang Y, Zhou X, Cheng P, Liu Y, et al. (2014) Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability. Clin Ther 36: 1087-1095 [CrossRef] [Google Scholar] [PubMed]
  32. Battaglia A, Dubini A, Mannheimer R, Pancheri P (2004) Depression in the Italian community: epidemiology and socio-economic implications. Int Clin Psychopharmacol 19: 135-142 [CrossRef] [Google Scholar] [PubMed]
  33. Callahan CM, Kesterson JG, Tierney WM (1997) Association of symptoms of depression with diagnostic test charges among older adults. Ann Intern Med 126: 426-432 [CrossRef] [Google Scholar] [PubMed]
  34. Vasiliadis HM, Dionne PA, Préville M, Gentil L, Berbiche D, et al. (2013) The excess healthcare costs associated with depression and anxiety in elderly living in the community. Am J Geriatr Psychiatry 21: 536-548 [CrossRef] [Google Scholar] [PubMed]
  35. Vasiliadis HM, Latimer E, Dionne PA, Préville M (2013) The costs associated with antidepressant use in depression and anxiety in community-living older adults. Can J Psychiatry 58: 201-209 [CrossRef] [Google Scholar] [PubMed]
  36. Haynes RB, McKibbon KA, Kanani R (1996) Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 348: 383-386 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.